(ASCO) ASCO Daily News, the official daily newspaper of the 2010 ASCO Annual Meeting, provides comprehensive and timely coverage of the most significant studies from the previous day’s scientific and educational sessions.
Studies Report Progress Against Breast Cancer
JUNE 07, 2010Amanda Stanley, ASCOStudies describing new advances against breast cancer were released June 6 at a press briefing at the 46th Annual Meeting of the American Society of Clinical Oncology.“The studies presented today provide us with new insight into the treatment and behavior of breast cancer, especially for difficult-to-treat metastatic disease,” said Eric P. Winer, MD, professor of medicine at Harvard Medical School, and moderator of the briefing. “We’re also learning the best ways to detect cancer spread in the lymph nodes, finding that in many cases, women can be spared from extensive, often painful, lymph node removal.”One study highlighted in the press briefing stated that a new agent, eribulin, derived from a marine sponge, increases survival among women with metastic breast cancer. A phase III randomized trial found that the chemotherapy agent, eribulin mesylate, extended median overall survival by 2.5 months among women with locally recurrent or metastatic breast cancer who had already been heavily treated with conventional therapies.Read more about the annual meeting on the ASCO website: www.asco.orgRead more about the eribulin discovery:
Drug eribulin boosted survival of dying patients by 10 weeks, study says, by Maggie Fox